Category: Uncategorized

For the past three days, Rhei Life participated in Duphat 2023, an unmissable pharmaceutical event in Middle East & Africa.

We are pleased to announce the latest addition to our management team with the appointment of Maksymilian Swiniarski, our new General Manager Poland and Western EU Markets.

We are pleased to announce that Rhei Life’s management team is strengthened with Mohamed Saeed as the new General Manager for MENA region. Mohamed is coming to our company from the position of Country Manager for Saudi Arabia in Galderma International, company he led to an annual revenue of more than 50 million dollars.

Rhei Life was a proud sponsor of regional conference on rare diseases “Caring for Rare” which brought together many eminent experts from leading European and regional institutions and organizations in the field of rare diseases. The conference gathered more than 100 participants and over 30 lecturers from almost 20 countries (Germany, Spain, Netherlands, UK, Italy, Slovenia, Slovakia, France, Finland, USA, Canada, Croatia, Macedonia, Bosnia and Herzegovina, Montenegro…).

We are proud to announce that Rhei Life have reached another important milestone by successfully passing the inspection of the Ministry of Health of the Republic of Serbia and receiving the license for the production of medicines in our manufacturing site in Vršac.

To our great satisfaction, as of August 1st, Rhei Life company’s management team is strengthened with Olga Petrović as new Business Development Manager for Serbia.

At our great satisfaction, Rhei Life is now officially present in the medicines market of Romania as well, with the placement of Sevatrim (inn: sulfametoxazole/trimethoprim).

At the end of last month, our company successfully completed the recertification process upon the ISO 9001:2015 standard with full compliance, confirming that all business processes and operation quality are in accordance with the highest relevant standards.

As of recently, Rhei Life has a new exclusive partner in its portfolio.

To contribute to the improvement of health care and quality of life of patients with rare diseases…